EW
SGMO

Evoke Wealth’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Evoke Wealth’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,250
Closed -$11K – 1233
2021
Q3 		$11K Buy
+1,250
New +$12.4K ﹤0.01% 735
2020
Q1 		– Sell
-156
Closed -$1.31K – 1314
2019
Q4 		$1.31K Hold
156
– – ﹤0.01% 1129
2019
Q3 		$1.41K Buy
+156
New +$1.75K ﹤0.01% 1273

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Evoke Wealth's SGMO Position: Q4 2021 in Review

Evoke Wealth sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2021, closing a stake of 1,250 shares — an estimated $11K sold.

Evoke Wealth first reported a position in SGMO in Q3 2019 and held it in 3 quarters. The position peaked at $11K in Q3 2021. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2021.

  • Evoke Wealth reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
  • Evoke Wealth sold 1,250 SANGAMO THERAPEUTICS INC shares in Q4 2021, an estimated $11K.
  • Evoke Wealth first reported a position in SANGAMO THERAPEUTICS INC in Q3 2019 and held it in 3 quarters.
  • Evoke Wealth's SANGAMO THERAPEUTICS INC position peaked at $11K in Q3 2021.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2021.

Based on Evoke Wealth's 13F filing for Q4 2021, filed 9 Feb 2022.